GIA
GILD icon

GHP Investment Advisors’s Gilead Sciences GILD Stock Holding History

GHP Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
12,971
+211
+2% +$27.8K 0.06% 252
2026
Q1 		$1.78M Buy
12,760
+118
+0.9% +$16.5K 0.07% 240
2025
Q4 		$1.55M Sell
12,642
-27
-0.2% -$3.28K 0.06% 248
2025
Q3 		$1.41M Buy
12,669
+156
+1% +$17.7K 0.06% 247
2025
Q2 		$1.39M Buy
12,513
+124
+1% +$13.2K 0.06% 248
2025
Q1 		$1.39M Buy
12,389
+1,035
+9% +$107K 0.07% 247
2024
Q4 		$1.05M Buy
11,354
+122
+1% +$11K 0.05% 267
2024
Q3 		$942K Buy
11,232
+631
+6% +$48.1K 0.04% 265
2024
Q2 		$727K Sell
10,601
-471
-4% -$31.4K 0.04% 278
2024
Q1 		$811K Buy
11,072
+144
+1% +$11.1K 0.04% 281
2023
Q4 		$885K Buy
10,928
+215
+2% +$16.7K 0.05% 272
2023
Q3 		$832K Sell
10,713
-1,113
-9% -$85.6K 0.05% 270
2023
Q2 		$946K Buy
11,826
+319
+3% +$25.4K 0.06% 264
2023
Q1 		$955K Buy
11,507
+538
+5% +$44.6K 0.06% 261
2022
Q4 		$942K Buy
10,969
+2,018
+23% +$160K 0.06% 257
2022
Q3 		$552K Buy
8,951
+153
+2% +$9.65K 0.04% 286
2022
Q2 		$544K Buy
8,798
+832
+10% +$51.5K 0.04% 281
2022
Q1 		$474K Sell
7,966
-525
-6% -$33.6K 0.03% 293
2021
Q4 		$616K Buy
8,491
+806
+10% +$55.5K 0.04% 240
2021
Q3 		$537K Buy
7,685
+633
+9% +$44.5K 0.04% 232
2021
Q2 		$486K Sell
7,052
-681
-9% -$45.5K 0.04% 232
2021
Q1 		$500K Buy
7,733
+115
+2% +$7.42K 0.04% 228
2020
Q4 		$444K Sell
7,618
-1,975
-21% -$119K 0.04% 228
2020
Q3 		$606K Sell
9,593
-1,579
-14% -$109K 0.07% 208
2020
Q2 		$860K Buy
11,172
+1,669
+18% +$128K 0.11% 184
2020
Q1 		$710K Buy
9,503
+1,560
+20% +$108K 0.11% 195
2019
Q4 		$516K Sell
7,943
-263
-3% -$17.1K 0.06% 231
2019
Q3 		$520K Buy
8,206
+721
+10% +$47.1K 0.06% 229
2019
Q2 		$506K Buy
7,485
+40
+0.5% +$2.63K 0.06% 231
2019
Q1 		$484K Buy
7,445
+564
+8% +$37.5K 0.06% 227
2018
Q4 		$430K Buy
6,881
+185
+3% +$12.9K 0.06% 223
2018
Q3 		$517K Sell
6,696
-708
-10% -$53.5K 0.07% 224
2018
Q2 		$525K Buy
7,404
+1,087
+17% +$76.8K 0.07% 224
2018
Q1 		$476K Buy
6,317
+923
+17% +$73.4K 0.07% 230
2017
Q4 		$386K Buy
5,394
+404
+8% +$30.7K 0.05% 245
2017
Q3 		$404K Buy
4,990
+12
+0.2% +$918 0.06% 245
2017
Q2 		$352K Buy
4,978
+1,479
+42% +$98.4K 0.06% 255
2017
Q1 		$238K Buy
3,499
+567
+19% +$39.9K 0.04% 275
2016
Q4 		$210K Buy
+2,932
New +$218K 0.04% 275

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GHP Investment Advisors's GILD Position: Q2 2026 in Review

GHP Investment Advisors increased its Gilead Sciences (GILD) stake by 1.7% in Q2 2026, buying an estimated $27.8K and bringing the position to 12,971 shares worth $1.64M. The position accounts for 0.06% of the portfolio, ranked #252.

GHP Investment Advisors first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.78M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • GHP Investment Advisors held 12,971 shares of Gilead Sciences worth $1.64M as of Q2 2026.
  • GHP Investment Advisors bought 211 Gilead Sciences shares in Q2 2026, an estimated $27.8K.
  • Gilead Sciences made up 0.06% of GHP Investment Advisors's portfolio in Q2 2026, its #252 holding.
  • GHP Investment Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
  • GHP Investment Advisors's Gilead Sciences position peaked at $1.78M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.